In a regulatory filing, Eli Lilly CAO Donald Zakrowski disclosed the sale of 750 common shares of the company on March 11 at a price of $753.60 per share.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on LLY:
- Eli Lilly announces results from ‘first-of-its-kind study’ of lebrikizumab
- Eli Lilly (NYSE:LLY) Slips after Surprise FDA Snub
- Eli Lilly falls $3.16 to $777 after FDA delays decision on Alzheimer’s drug
- Eli Lilly reports FDA to convene PCNS meeting to discuss TRAILBLAZER-ALZ 2 trial
- Viking Therapeutics initiated with a Buy at Jefferies
